ondasdechoque.org
PT-BR
A patient guide to the research

Shockwave research, explained

Each study read in full: who took part, what shockwave was compared with, and what changed.

166full-text analyses
53randomized trials
65systematic syntheses
1996–2026publication years
See the studies ↓

Research reports

166 of 166 reports

Explore collection statistics

Counts describe publications. Participant totals are not added across reports.

Reports by publication year

  1. 202634
  2. 202525
  3. 202422
  4. 202317
  5. 20229
  6. 20212
  7. 20203
  8. 20194
  9. 20184
  10. 20175
  11. 20161
  12. 20155
  13. 20142
  14. 20133
  15. 20124
  16. 20112
  17. 20103
  18. 20094
  19. 20084
  20. 20072
  21. 20062
  22. 20051
  23. 20042
  24. 20032
  25. 20022
  26. 20011
  27. 19961

Reports by publication type

  1. Systematic review with meta-analysis22
  2. Randomized comparative clinical trial15
  3. Systematic review with network meta-analysis12
  4. Randomized trials7
  5. Systematic clinical review6
  6. clinical synthesis5
  7. Randomized trial with sham / placebo control5
  8. Narrative review4
  9. nonrandom comparative4
  10. randomized trial4
  11. Randomized treatment-schedule comparison3
  12. Randomized trial3
  13. Umbrella review3
  14. Uncontrolled studies3
  15. mixed translational2
  16. Nonrandomized comparative study2
  17. Randomized adjunct-treatment trial2
  18. Retrospective treated-cohort prognostic study2
  19. Systematic review and meta-analysis2
  20. Clinical guideline supported by an evidence review1
  21. Comparative evidence synthesis with meta-analysis1
  22. Controlled laboratory animal experiment with 36 male Sprague Dawley rats divided equally among three groups. Random allocation and blinded outcome assessment are not clearly described. No human patients were enrolled.1
  23. Double-blind sham-controlled randomized trial in Denmark; computer-generated list concealed in numbered envelopes. Forty-eight randomized, 24 per group; 22 active and 23 sham patients were examined at 12 weeks.1
  24. Exploratory secondary analysis of a feasibility trial1
  25. Graded literature review titled meta-analysis, without statistical pooling1
  26. Letter to the editor1
  27. Meta-analysis of long-term comparative trials1
  28. Mixed clinical / preclinical1
  29. Multiple single-case experiments with randomized baseline length1
  30. Narrative management review with selected randomized trials organized by indication. It is not a new trial or a systematic meta-analysis, and no reproducible search or formal certainty grading is supplied.1
  31. Narrative mechanistic review combining cell studies, animal experiments, human anatomical/experimental pain studies and selected clinical reports. It presents no systematic search, pooled efficacy estimate or new controlled experiment.1
  32. Narrative mini review1
  33. Narrative practice review1
  34. Narrative review and clinical commentary1
  35. Narrative review of animal, cell and selected clinical studies1
  36. Narrative review of laboratory and animal studies1
  37. Narrative review of shockwave technology, experimental mechanisms and selected clinical studies. No reproducible systematic search, pooled analysis or formal risk-of-bias assessment is presented.1
  38. Narrative review with a stated structured search (PubMed, EMBASE, Web of Science and Cochrane Library to July 2026; 85 studies included) covering cell-signalling, animal and clinical studies of shockwaves in knee osteoarthritis. It has a PRISMA-style flow chart but no risk-of-bias appraisal and no pooled estimate, and it included English-language articles only.1
  39. Narrative technology review with a systematic clinical component1
  40. Nonrandomized comparisons1
  41. Open-label randomized trial of two focused-shockwave targets1
  42. Perspective (narrative review with author-assigned certainty grades)1
  43. Placebo-controlled double-blind randomized trial1
  44. Pooled secondary analysis of randomized-trial datasets1
  45. Post hoc analysis of a randomized trial1
  46. PRISMA-ScR scoping review of English-language human interventional and observational studies in PubMed through December 2021. Nineteen studies were included from 76 search records; no pooled effect or formal certainty assessment is supplied.1
  47. Prospective randomized comparative study. Forty-six patients were allocated; six with missing assessments were excluded and 40 were analyzed. The random sequence, allocation concealment and assessor masking are not described.1
  48. Prospective randomized patient-blinded pilot trial in Poland; computer-generated allocation and coded statistical analysis. Forty of 52 screened patients entered, 20 per group; control follow-up declined to 19 at one month and 17 at three months.1
  49. Randomized feasibility trial1
  50. Randomized pilot trial with random-number block allocation and opaque envelopes; patients and follow-up assessors were blinded. Thirty participants were analyzed. The flow describes 37 assessed, six declining after symptom relief and one follow-up loss.1
  51. Randomized sham-controlled trial; per-protocol primary analysis1
  52. Randomized trial with acute mechanistic outcomes1
  53. Randomized trial with later elective crossover1
  54. Retrospective nonrandomized treatment comparison1
  55. Retrospective single-cohort before-after study1
  56. Scoping / narrative review1
  57. Scoping review of primary studies harvested from seven existing reviews/meta-analyses identified through PubMed, PEDro and Cochrane to August 2025. Of 83 extracted records, 48 duplicates were removed and 35 articles analyzed. This is a methodological audit, not a new efficacy meta-analysis.1
  58. Secondary individual-participant analysis of active-treatment arms1
  59. Secondary trajectory analysis of a randomized trial1
  60. Sham-controlled double-blind randomized trial1
  61. Short narrative review of animal, cell and selected clinical studies of shockwave treatment for knee osteoarthritis. It describes no search method, inclusion criteria, quality appraisal or pooled estimate, and the authors state that they set out to give a positive overview.1
  62. Single-arm intervention and prediction-model study1
  63. Single-blind prospective randomized trial, computer-generated allocation in sealed packets. Forty-five participants were randomized equally; 41 completed and were analyzed: 13 control, 13 shockwave, 15 combined. Masking of subjective treatment experiences was not feasible.1
  64. Single-center, single-blinded, placebo-controlled randomized trial in China. 70 of 186 screened patients randomized, 36 placebo and 34 shockwave; 31 and 30 completed 12 weeks. Allocation concealment not described; no registration reported.1
  65. Single-centre observational proof-of-concept diagnostic study, without blinded comparison, independent reference standard or treatment efficacy follow-up.1
  66. Single-centre prospective cohort in which all 28 patients received one session of focused shockwave therapy, with serum biomarker measurements. The authors call it a case–control study, but there is no untreated or sham group: the two groups compared are radiodense (Gärtner type I) and radiolucent (type II/III) deposits, all treated the same way.1
  67. Single-centre randomized, assessor-blinded, sham-controlled trial, registered NCT02221011. An independent researcher used computer-generated block allocation, 1:1:1; 60 participants completed follow-up.1
  68. Systematic mechanistic review with human, animal and laboratory components1
  69. Systematic review and meta-analysis of randomized trials1
  70. Systematic review and random-effects meta-analysis of 10 randomized trials, searched through 30 April 2021 across databases, registries and grey literature; protocol CRD 42021250013. Risk of bias, Jadad and GRADE assessments were used.1
  71. Systematic review combining primary studies and reviews1
  72. Systematic review of human and preclinical studies1
  73. Systematic review of mechanistic studies in human tissue1
  74. Systematic review with before-after meta-analysis1
  75. Systematic review with meta-analysis of controlled clinical studies, searching four databases to October 2021 in English. Nonrandomized and allocation-unclear studies were eligible. The abstract says eight studies, whereas the flowchart, Table 1 and Discussion identify ten.1
  76. Theoretical physics paper with clinical hypotheses1
  77. Two-group comparative study at one Korean hospital; allocation method not described (treated as allocation-unclear). 30 patients, 15 per group; analysed numbers and dropouts not reported; outcomes at end of 6-week treatment only.1
  78. uncontrolled clinical1
  79. Uncontrolled repeated-measures clinical study1